Growth Metrics

Invivyd (IVVD) R&D In Process (2021 - 2023)

Invivyd posted quarterly R&D In Process of -$600000.0 for Q4 2023, down 250.0% year-on-year from $400000.0 in Q4 2022, and down 113.04% on a QoQ basis from $4.6 million in Q3 2023.

Invivyd (IVVD) has 3 years of R&D In Process data on file, last reported at -$600000.0 in Q4 2023.

  • For the quarter ending Q4 2023, R&D In Process fell 250.0% year-over-year to -$600000.0; the trailing twelve-month figure through Sep 2024 stood at -$600000.0 (down 110.04% YoY), and the FY2023 full-year result was $5.0 million, up 13.07% from the prior year.
  • R&D In Process for Q4 2023 stood at -$600000.0, down from $4.6 million in the prior quarter.
  • Across five years, R&D In Process topped out at $4.6 million in Q3 2023 and bottomed at -$600000.0 in Q4 2023.
  • The 3-year median for R&D In Process is $1.0 million (2021), against an average of $1.9 million.
  • Peak annual rise in R&D In Process reached 15.0% in 2023, while the deepest fall reached 250.0% in 2023.
  • A 3-year view of R&D In Process shows it stood at $4.0 million in 2021, then plunged by 90.0% to $400000.0 in 2022, then slumped by 250.0% to -$600000.0 in 2023.
  • The last three R&D In Process figures came in at -$600000.0 (Q4 2023), $4.6 million (Q3 2023), and $150000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D In Process (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 500,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 101.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Invivyd 208.38 Mn -18.31 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -600,000.00
Sep 30, 2023 4.60 Mn
Jun 30, 2023 150,000.00
Mar 31, 2023 825,000.00
Dec 31, 2022 400,000.00
Sep 30, 2022 4.00 Mn
Sep 30, 2021 4.00 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 1.00 Mn